The ACHN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACHN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ACHN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ACHN Detailed Price Forecast - CNN Money||View ACHN Detailed Summary - Google Finance|
|View ACHN Detailed Summary - Yahoo! Finance||View ACHN Stock Research & Analysis - Zacks.com|
|View ACHN Trends & Analysis - Trade-Ideas||View ACHN Major Holders - Barrons|
|View ACHN Call Transcripts - NASDAQ||View ACHN Breaking News & Analysis - Seeking Alpha|
|View ACHN Annual Report - CompanySpotlight.com||View ACHN OTC Short Report - OTCShortReport.com|
|View ACHN Fundamentals - TradeKing||View ACHN SEC Filings - Bar Chart|
|View Historical Prices for ACHN - The WSJ||View Performance/Total Return for ACHN - Morningstar|
|View the Analyst Estimates for ACHN - MarketWatch||View the Earnings History for ACHN - CNBC|
|View the ACHN Earnings - StockMarketWatch||View ACHN Buy or Sell Recommendations - MacroAxis|
|View the ACHN Bullish Patterns - American Bulls||View ACHN Short Pain Metrics - ShortPainBot.com|
|View ACHN Stock Mentions - StockTwits||View ACHN Stock Mentions - PennyStockTweets|
|View ACHN Stock Mentions - Twitter||View ACHN Investment Forum News - Investor Hub|
|View ACHN Stock Mentions - Yahoo! Message Board||View ACHN Stock Mentions - Seeking Alpha|
|View Insider Transactions for ACHN - SECform4.com||View Insider Transactions for ACHN - Insider Cow|
|View ACHN Major Holdings Summary - CNBC||View Insider Disclosure for ACHN - OTC Markets|
|View Insider Transactions for ACHN - Yahoo! Finance||View Institutional Holdings for ACHN - NASDAQ|
|View ACHN Stock Insight & Charts - FinViz.com||View ACHN Investment Charts - StockCharts.com|
|View ACHN Stock Overview & Charts - BarChart||View ACHN User Generated Charts - Trading View|
Research Report Identifies The Goodyear Tire & Rubber, Prudential Financial, PennyMac Mortgage Investment Trust, Achillion Pharmaceuticals, American Software, and Lantheus with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
Posted on Tuesday February 12, 2019
NEW YORK, Feb. 12, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Achillion Appoints Brian Di Donato as Chief Financial Officer
Posted on Monday February 11, 2019
Achillion Pharmaceuticals, Inc. (ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families affected by complement-mediated diseases, today announced the appointment of Brian Di Donato to the position of Senior Vice President and Chief Financial Officer, effective immediately. Mr. Di Donato has over 20 years of financial and leadership experience and will assume responsibility for finance, accounting and treasury as well as continue to lead investor relations. “Brian joined the Achillion team in August 2018 and has already made significant contributions alongside the new management team as we accelerate our clinical programs and prepare for registrational trials,” commented Joseph Truitt, President and Chief Executive Officer of Achillion.
Alexion's (ALXN) Earnings Beat Estimates in Q4, Shares Up
Posted on Monday February 04, 2019
Alexion (ALXN) exceeds earnings and sales estimates in the fourth quarter of 2018 on strong performance by Soliris.
- ACH-5228, with improved potency and half-life, increases alternative pathway inhibition -- Achillion planning Investigational New Drug (IND) submission in fourth quarter of.